INDOLIZINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
申请人:LES LABORATOIRES SERVIER
公开号:US20150051189A1
公开(公告)日:2015-02-19
Compounds of formula (I):
wherein R
a
, R
b
, R
c
, R
d
, R
1
, R
2
, R
3
, R
4
, R
5
, X, Y and Het are as defined in the description.
Medicinal products containing the same which are useful in treating pathologies involving a deficit in apoptosis, such as cancer, auto-immune diseases, and diseases of the immune system.
式(I)的化合物:
其中R
a
,R
b
,R
c
,R
d
,R
1
,R
2
,R
3
,R
4
,R
5
,X,Y和Het如描述中所定义。
含有相同化合物的药物,对于治疗涉及凋亡缺陷的病理,如癌症、自身免疫疾病和免疫系统疾病,具有益处。